Immune checkpoint inhibitors (ICIs) have revolutionized the field of cancer immuno-oncology.  ICIs act on cancer cells by blocking the interaction bet



Summary

Immune checkpoint inhibitors (ICIs) are a groundbreaking cancer therapy that boosts the body’s natural defenses. They work by targeting proteins (immune checkpoints) on immune cells like T cells or on cancer cells themselves. Blocking these checkpoints, which normally suppress immune activity, unleashes the T cells’ ability to recognize and destroy cancer cells. This approach has shown significant success in treating various cancers, offering a new avenue for durable responses and improved patient outcomes by harnessing the power of the immune system to fight cancer.

Read more…

Credits: Source

This post is part of “Science/Immunology News”, Follow for more…!!!